<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">137540</id>
  <title nil="true"/>
  <common-name>Copper oxodotreotide Cu-64</common-name>
  <description>Copper oxodotreotide Cu-64 belongs to the amino acids, peptides, and analogues, a subclass of carboxylic acids and derivatives within the organic compounds. With an average molecular weight of 1,498 g/mol, Copper oxodotreotide Cu-64 is a heavy molecule. It has the chemical formula C65H88CuN14O19S2. In terms of biological activity, one protein target has been recorded for this compound, as it acts as a binder of Somatostatin receptor type 2 (SSTR2).</description>
  <cas>1426155-87-4</cas>
  <pubchem-id nil="true"/>
  <chemical-formula>C65H88CuN14O19S2</chemical-formula>
  <weight nil="true"/>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-04-14T20:29:20Z</created-at>
  <updated-at type="dateTime">2026-05-14T19:53:18Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id>DB15873</drugbank-id>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>[64Cu++].C[C@@H](O)[C@H](NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)CN2CCN(CC(O)=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC2)C(=O)N[C@@H](CC2=CC=C(O)C=C2)C(=O)N[C@H](CC2=CNC3=C2C=CC=C3)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1)C(O)=O</moldb-smiles>
  <moldb-formula>C65H88CuN14O19S2</moldb-formula>
  <moldb-inchi>InChI=1S/C65H90N14O19S2.Cu/c1-38(80)56-64(96)73-51(63(95)75-57(39(2)81)65(97)98)37-100-99-36-50(72-59(91)47(28-40-10-4-3-5-11-40)68-52(83)32-76-20-22-77(33-53(84)85)24-26-79(35-55(88)89)27-25-78(23-21-76)34-54(86)87)62(94)70-48(29-41-15-17-43(82)18-16-41)60(92)71-49(30-42-31-67-45-13-7-6-12-44(42)45)61(93)69-46(58(90)74-56)14-8-9-19-66;/h3-7,10-13,15-18,31,38-39,46-51,56-57,67,80-82H,8-9,14,19-30,32-37,66H2,1-2H3,(H,68,83)(H,69,93)(H,70,94)(H,71,92)(H,72,91)(H,73,96)(H,74,90)(H,75,95)(H,84,85)(H,86,87)(H,88,89)(H,97,98);/q;+2/p-2/t38-,39-,46+,47-,48+,49-,50+,51+,56+,57+;/m1./s1/i;1+0</moldb-inchi>
  <moldb-inchikey>IJRLLVFQGCCPPI-NVGRTJHCSA-L</moldb-inchikey>
  <moldb-average-mass type="decimal">1497.55</moldb-average-mass>
  <moldb-mono-mass type="decimal">1496.508926883</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>-8.4</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM133433</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>(64Cu)copper(2+) 2-[7-({[(1R)-1-{[(4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-4-{[(1S,2R)-1-carboxy-2-hydroxypropyl]carbamoyl}-7-[(1R)-1-hydroxyethyl]-16-[(4-hydroxyphenyl)methyl]-13-[(1H-indol-3-yl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-19-yl]carbamoyl}-2-phenylethyl]carbamoyl}methyl)-4-(carboxylatomethyl)-10-(carboxymethyl)-1,4,7,10-tetraazacyclododecan-1-yl]acetate</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Organic acids and derivatives</superklass>
  <klass>Carboxylic acids and derivatives</klass>
  <subklass>Amino acids, peptides, and analogues</subklass>
  <paper-count type="integer">90</paper-count>
  <sync-id>CED0019600</sync-id>
  <structure-inchikey>IJRLLVFQGCCPPI-NVGRTJHCSA-L</structure-inchikey>
  <structure-fingerprint>4000000000400000002180000000150000000000000000000000000010000000000004300004322000820000102800001400200000001000006000200000000400000000000000040000000080080000002000001001400000100000804000000000400003000808800000400010000000000402010000040000040000020010002100004020002080000022000000008000100080010000002000088000000000000000c00000010404000008000000000000000000800000800002200c000001000040040000002100800000000000000000440000000001500220000021010000008008008800400041008000010490004000000000000000820000000000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAABlAAAAaQAAAIABHSCCAQAAAgFAAAAABgBg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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T04:50:26Z</structure-indexed-at>
</compound>
